$INGN
Inogen Inc

2020 Q2 Form 10-Q Financial Statement

#000156459020036195 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $71.69M $101.1M $90.20M
YoY Change -29.06% 3.93% 14.11%
Cost Of Revenue $38.90M $50.85M $45.79M
YoY Change -23.5% 4.27% 10.81%
Gross Profit $32.75M $50.22M $44.41M
YoY Change -34.78% 3.6% 17.71%
Gross Profit Margin 45.68% 49.69% 49.23%
Selling, General & Admin $32.40M $36.60M $37.88M
YoY Change -11.48% 11.93% 37.2%
% of Gross Profit 98.93% 72.89% 85.3%
Research & Development $3.300M $1.500M $1.669M
YoY Change 120.0% -16.67% 17.87%
% of Gross Profit 10.08% 2.99% 3.76%
Depreciation & Amortization $4.480M $2.760M $2.794M
YoY Change 62.32% -2.13% -6.65%
% of Gross Profit 13.68% 5.5% 6.29%
Operating Expenses $35.70M $38.10M $39.55M
YoY Change -6.3% 10.76% 36.26%
Operating Profit -$2.951M $12.11M $4.858M
YoY Change -124.36% -13.89% -44.16%
Interest Expense $200.0K $1.400M $1.300M
YoY Change -85.71% 100.0% 160.0%
% of Operating Profit 11.56% 26.76%
Other Income/Expense, Net $100.0K $1.539M $1.214M
YoY Change -93.5% -510.4% 23.0%
Pretax Income $3.525M $13.68M $6.072M
YoY Change -74.24% 0.28% -37.32%
Income Tax $945.0K $3.524M $770.0K
% Of Pretax Income 26.81% 25.75% 12.68%
Net Earnings $2.580M $10.16M $5.302M
YoY Change -74.61% -30.46% -50.72%
Net Earnings / Revenue 3.6% 10.05% 5.88%
Basic Earnings Per Share $0.12 $0.47 $0.24
Diluted Earnings Per Share $0.12 $0.45 $0.24
COMMON SHARES
Basic Shares Outstanding 21.96M 21.82M 21.75M
Diluted Shares Outstanding 22.22M 22.36M 22.53M

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $218.6M $256.1M $239.2M
YoY Change -14.65% 22.91% 27.03%
Cash & Equivalents $214.1M $213.9M $190.2M
Short-Term Investments $4.549M $42.20M $49.00M
Other Short-Term Assets $16.50M $10.70M $9.600M
YoY Change 54.21% 50.7% 134.15%
Inventory $36.18M $24.49M $28.80M
Prepaid Expenses
Receivables $28.42M $46.72M $41.50M
Other Receivables $3.000M $2.800M $2.600M
Total Short-Term Assets $302.8M $340.7M $321.8M
YoY Change -11.13% 20.4% 28.16%
LONG-TERM ASSETS
Property, Plant & Equipment $21.53M $21.36M $27.90M
YoY Change 0.79% -2.9% 33.49%
Goodwill $32.96M $2.242M
YoY Change 1369.98% -2.69%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.20M $4.793M $32.90M
YoY Change 279.72% -77.5% 56.67%
Total Long-Term Assets $155.3M $63.05M $66.40M
YoY Change 146.32% 27.11% 36.07%
TOTAL ASSETS
Total Short-Term Assets $302.8M $340.7M $321.8M
Total Long-Term Assets $155.3M $63.05M $66.40M
Total Assets $458.1M $403.8M $388.2M
YoY Change 13.45% 21.4% 29.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.20M $16.07M $14.50M
YoY Change -17.86% -9.83% 6.7%
Accrued Expenses $17.40M $12.00M $13.10M
YoY Change 45.0% -6.98% 29.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.60M $46.40M $43.80M
YoY Change 9.05% -1.69% 16.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $56.30M $23.40M $22.30M
YoY Change 140.6% 2394.67% 43.87%
Total Long-Term Liabilities $56.30M $23.40M $22.30M
YoY Change 140.6% 2394.67% 43.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.60M $46.40M $43.80M
Total Long-Term Liabilities $56.30M $23.40M $22.30M
Total Liabilities $107.0M $70.00M $66.30M
YoY Change 52.86% 6.5% 23.93%
SHAREHOLDERS EQUITY
Retained Earnings $65.79M
YoY Change
Common Stock $255.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $351.1M $333.8M $321.9M
YoY Change
Total Liabilities & Shareholders Equity $458.1M $403.8M $388.2M
YoY Change 13.45% 21.4% 29.44%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income $2.580M $10.16M $5.302M
YoY Change -74.61% -30.46% -50.72%
Depreciation, Depletion And Amortization $4.480M $2.760M $2.794M
YoY Change 62.32% -2.13% -6.65%
Cash From Operating Activities $13.53M $18.42M -$1.824M
YoY Change -26.55% -12.37% -114.9%
INVESTING ACTIVITIES
Capital Expenditures -$3.560M -$1.070M $933.0K
YoY Change 232.71% -56.5% -55.04%
Acquisitions
YoY Change
Other Investing Activities -$4.490M $6.190M -$6.020M
YoY Change -172.54% -168.78% 53.96%
Cash From Investing Activities -$8.050M $5.120M -$6.948M
YoY Change -257.23% -144.68% 16.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K 170.0K 2.446M
YoY Change -64.71% -91.71% -52.46%
NET CHANGE
Cash From Operating Activities 13.53M 18.42M -1.824M
Cash From Investing Activities -8.050M 5.120M -6.948M
Cash From Financing Activities 60.00K 170.0K 2.446M
Net Change In Cash 5.540M 23.71M -6.398M
YoY Change -76.63% 104.22% -156.14%
FREE CASH FLOW
Cash From Operating Activities $13.53M $18.42M -$1.824M
Capital Expenditures -$3.560M -$1.070M $933.0K
Free Cash Flow $17.09M $19.49M -$2.757M
YoY Change -12.31% -16.99% -127.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
11057000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y4M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y4M2D
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180681000
ingn Rental Revenue Net
RentalRevenueNet
10584000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19756000
CY2019Q2 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
8000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5855000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13768000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14452000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77533000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2753000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4294000
us-gaap Net Income Loss
NetIncomeLoss
15462000
CY2019Q4 ingn Rental Equipment Net Of Allowances
RentalEquipmentNetOfAllowances
39308000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19438000
CY2019Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
2976000
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4388000
CY2019Q4 us-gaap Goodwill
Goodwill
32954000
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9704000
CY2019Q4 ingn Land And Building
LandAndBuilding
125000
CY2019Q4 ingn Computer Equipment And Software Gross
ComputerEquipmentAndSoftwareGross
7266000
CY2019Q4 ingn Construction In Process
ConstructionInProcess
1773000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10160000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64294000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
292219000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34325000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44856000
CY2019Q4 us-gaap Inventory Net
InventoryNet
35664000
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1730000
ingn Cost Of Rental
CostOfRental
7344000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13541000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
87000
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
3299000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
87000
ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
91384000
us-gaap Cost Of Revenue
CostOfRevenue
96641000
ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
3240000
CY2019Q4 ingn Earnout Liability Noncurrent
EarnoutLiabilityNoncurrent
26559000
us-gaap Gross Profit
GrossProfit
94624000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-104000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
351114000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3137000
us-gaap Operating Expenses
OperatingExpenses
77621000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18525000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55959000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-534000
us-gaap Operating Income Loss
OperatingIncomeLoss
17003000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2728000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
36000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21783150
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-71000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1779000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15391000
CY2020Q2 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
4000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22459101
CY2020Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
61000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-76000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-458000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
321894000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40150000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1832000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17313000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
196634000
ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
1481000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
208000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
242000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1973000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
104000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1878000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1525000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
785000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2618000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-76000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
214086000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1959000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
163000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2580000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
310424000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1525000
ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
67000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
718000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1878000
us-gaap Net Income Loss
NetIncomeLoss
15462000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-71000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
333798000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
344621000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4061000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1088000
ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
11000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
227000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
186000
us-gaap Net Income Loss
NetIncomeLoss
991000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
405000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
351114000
us-gaap Net Income Loss
NetIncomeLoss
991000
us-gaap Net Income Loss
NetIncomeLoss
15462000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8942000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5554000
ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-279000
ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-323000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
74000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
46000
ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
5694000
ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
8890000
ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
1227000
us-gaap Share Based Compensation
ShareBasedCompensation
4061000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
684000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4067000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-20000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1399000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3327000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
8000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
95000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6385000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3154000
ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
3599000
ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
5461000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1509000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1926000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1124000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
223000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
190000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4436000
ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
1237000
ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
795000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
282000
ingn Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3800000
ingn Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
6462000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
238000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1036000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16049000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-832000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14070000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16603000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4554000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
38601000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11057000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
215000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2329000
ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
3227000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
119000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
851000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
186000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1088000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198037000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
132000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
146000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition and determining the stand-alone selling price (SSP) of performance obligations, inventory and rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, warranty expense, stock compensation expense, depreciation and amortization, income tax provision and uncertain tax positions, fair value of financial instruments, fair value of acquired intangible assets and goodwill and fair value of earnout liabilities. Actual results could differ from these estimates.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21783150
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
73253000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
405000
CY2020Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
54332000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
51560000
CY2020Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
159754000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
146477000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214086000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198037000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4549000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
11057000
CY2020Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1520000
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
590000
CY2020Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
29775000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
36104000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28422000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34325000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1779000
CY2020Q2 ingn Doubtful Accounts
DoubtfulAccounts
141000
CY2019Q4 ingn Doubtful Accounts
DoubtfulAccounts
205000
CY2020Q2 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
544000
CY2019Q4 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
411000
CY2020Q2 ingn Allowances For Sales Returns
AllowancesForSalesReturns
668000
CY2019Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
1163000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1353000
CY2020Q2 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.772
CY2019Q2 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.718
ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.722
ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.716
CY2020Q2 us-gaap Revenues
Revenues
71691000
CY2019Q2 us-gaap Revenues
Revenues
101063000
us-gaap Revenues
Revenues
160180000
us-gaap Revenues
Revenues
191265000
CY2020Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
31925000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5085000
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
830000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1779000
CY2020Q2 us-gaap Inventory Net
InventoryNet
36180000
CY2019Q4 us-gaap Inventory Net
InventoryNet
35664000
CY2020Q2 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
0
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1123000
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1363000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2230000
CY2020Q1 ingn Rental Equipment Allowance
RentalEquipmentAllowance
355000
CY2019Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
395000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66911000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64294000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45381000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44856000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21530000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19438000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019Q4 us-gaap Goodwill
Goodwill
32954000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-3000
CY2020Q2 us-gaap Goodwill
Goodwill
32957000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2250000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
324000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4492000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
652000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84499000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11246000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
73253000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84282000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6749000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77533000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4506000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8723000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8410000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7835000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
7830000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
35949000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29363000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
30730000
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
87000
CY2020Q2 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
3157000
CY2019Q4 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
3158000
CY2020Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2488000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2169000
CY2020Q2 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
756000
CY2019Q4 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
801000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6405000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6215000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend the leases for up to 5 years.
us-gaap Operating Lease Payments
OperatingLeasePayments
1183000
us-gaap Operating Lease Payments
OperatingLeasePayments
1164000
us-gaap Operating Lease Cost
OperatingLeaseCost
1344000
us-gaap Operating Lease Cost
OperatingLeaseCost
1087000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4667000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6418000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
2143000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
1971000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
1752000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
1757000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
846000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
3344000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11813000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1297000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10516000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1823000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8693000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10516000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2580000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
10160000
us-gaap Net Income Loss
NetIncomeLoss
991000
us-gaap Net Income Loss
NetIncomeLoss
15462000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21963472
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21815634
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21939919
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22221356
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22359679
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22229744
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22459101
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21963472
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21815634
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21939919
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21783150
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
257884
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
544045
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
289825
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
675951
CY2020Q2 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22221356
CY2019Q2 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22359679
ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22229744
ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22459101
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
701245
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225165
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300712
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165060
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
980884
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.24
CY2019 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
34.07
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9324
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3784
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
51.44
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
967776
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.33
ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
7.62
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
967776
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
35.33
CY2020Q2 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
7.62
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
967776
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.33
CY2020Q2 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
7.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6870000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1277000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
269000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1277000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
12571000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2845000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1779000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4061000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5365000
CY2020Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
289000
CY2020Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
457000
CY2020Q2 us-gaap Contractual Obligation
ContractualObligation
746000
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
68200000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
12571000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9530000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4914000
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8131000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-304000
CY2019 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1433000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3373000
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6523000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13808000
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2594000
CY2019Q2 ingn Number Of Lawsuits
NumberOfLawsuits
2
CY2019Q4 ingn Number Of Additional Shareholder Derivative Who Filed Lawsuits
NumberOfAdditionalShareholderDerivativeWhoFiledLawsuits
3
CY2020Q1 ingn Number Of Consolidated Shareholder Derivative Lawsuits
NumberOfConsolidatedShareholderDerivativeLawsuits
4
CY2020Q2 ingn Number Of Consolidated Shareholder Derivative Lawsuits
NumberOfConsolidatedShareholderDerivativeLawsuits
2
CY2020Q2 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
5
CY2020Q2 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
1
CY2019Q2 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
13
CY2019Q2 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
3

Files In Submission

Name View Source Status
0001564590-20-036195-index-headers.html Edgar Link pending
0001564590-20-036195-index.html Edgar Link pending
0001564590-20-036195.txt Edgar Link pending
0001564590-20-036195-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingn-10q_20200630.htm Edgar Link pending
ingn-10q_20200630_htm.xml Edgar Link completed
ingn-20200630.xsd Edgar Link pending
ingn-20200630_cal.xml Edgar Link unprocessable
ingn-20200630_def.xml Edgar Link unprocessable
ingn-20200630_lab.xml Edgar Link unprocessable
ingn-20200630_pre.xml Edgar Link unprocessable
ingn-ex101_89.htm Edgar Link pending
ingn-ex311_7.htm Edgar Link pending
ingn-ex312_6.htm Edgar Link pending
ingn-ex321_8.htm Edgar Link pending
ingn-ex322_9.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending